SENSEX
NIFTY
GOLD
USD/INR

Weather

16    C

Health & Fitness / The Wall Street Journal

Biogens Alzheimers Revelation Isnt So Simple

Investors were shocked to learn that Biogen now plans to pursue regulatory approval for the experimental Alzheimers disease drug they previously pulled the plug on. But Heard on the Street's Charley Grant explains why the optimism may be premature. Photo: Brian Snyder/Reuters

23 Oct 2019 3:37 am